TABLE 3.
Final model of the change in QTcF after dosea
| Parameter | Value (% RSE) |
|---|---|
| Typical ΔQTcF in all participants, θTYP (ms) | 3.7 (44.6) |
| Effect of taking both clofazimine and moxifloxacin on ΔQTcF, θCFZ+MFX (ms) | 13.0 (55.4) |
| Effect of age on ΔQTcF, θage (ms/yr) | 1.3 (24.6) |
| Effect of predose QTcF on ΔQTcF, (ms/10 ms) | −3.4 (14.0) |
| Between-subject variability, ηBSV (ms) | 7.2 (20.8) |
| Between-occasion variability, ηBOV (ms) | 9.2 (12.8) |
| Residual additive error, ε (ms) | 11.1 (4.2) |